You've just added:

Home / News

News + Media

May 09, 2022

Looking at Alzheimer’s Differently

Understanding Alzheimer’s remains the scientific challenge of our generation. Seeing a challenge and unmet need, Alzheimer’s researchers supported by Harrington Discovery Institute are attacking the disease in novel ways, with some early successes. Continue Reading

April 13, 2022

A Breakthrough Topical Treatment for Skin Cancer

Dr. Tang, Stanford University, Harrington Scholar, is developing patidegib, a therapry that will hopefully be the first topical drug that is safe and efficacious for Basal Cell Carcinoma (BCC) tumors (skin cancer) prevention. Continue Reading

March 24, 2022

International Harrington Prize Jointly Awarded to Drs. James Crowe and Michel Nussenzweig

2022 Harrington Prize for Innovation in Medicine Recognizes Breakthrough Innovations in the Use of Human Antibodies to Treat COVID-19March 24, 2022, Cleveland, Ohio – The ninth annual Harrington Prize for Innovation in Medicine has been jointly awarded to James E. Crowe, Jr., MD, Director, Vanderbilt Vaccine Center and... Continue Reading

March 07, 2022

Advancing Novel Treatments for Rare Neurological Diseases

In honor of Rare Disease Day 2022, The Oxford-Harrington Rare Disease Centre (OHC) hosted a Rare Disease Day Webinar, Advancing Novel Treatments for Neurological Rare Diseases, on Monday, February 28. The Oxford-Harrington Rare Disease Centre is a partnership between Harrington Discovery Institute at University Hospitals and... Continue Reading

February 23, 2022

Harrington Discovery Institute Opens Call for 2023 Harrington Scholar-Innovator Award

February 23, 2022, CLEVELAND, Ohio USA - Harrington Discovery Institute at University Hospitals is now accepting the Letters of Intent for the 2023 Harrington Scholar-Innovator Award for physician-scientists. The award offers successful applicants financial resources and expertise to advance their discoveries toward clinical... Continue Reading

January 24, 2022

Linda and Les Vinney Scholar Program to Support New Treatments for Alzheimer’s Disease

Linda and Les Vinney committed $1.25 million to establish the Linda and Les Vinney Scholar Program at Harrington Discovery Institute's Center for Brain Health Medicine, which will support new treatments for patients living with Alzheimer's disease. The gift also creates the Linda and Les Vinney Acceleration Awards, which will... Continue Reading

January 18, 2022

Harrington Discovery Institute Advances COVID-19 Treatments

Four Medicines in Clinical Trials and More in the Pipeline When it came to vaccines being trialed to prevent COVID-19, University Hospitals was already at the national forefront of innovations advancing COVID-19 treatments in mid-2020.Now four Scholars at Harrington Discovery Institute at University Hospitals might well be... Continue Reading

January 01, 2022

Harrington Discovery Institute Origin Story

Harrington Discovery Institute advances scientific breakthroughs, accelerates drug development, and impacts the standard of care. We cure diseases, together. In 2012, a $50 million transformative gift from Ron and Nancy Harrington and their children Jill, Ron, and Lydia Harrington, made possible the vision of Dr. Jonathan... Continue Reading

December 09, 2021

LSU And Takeda Partner To Advance Harrington Scholar’s Therapy For Rare Neurological Disorders

New Orleans, LA – LSU Health New Orleans entered into an exclusive option and license agreement with Takeda Pharmaceutical Company Limited (“Takeda”) granting Takeda the exclusive right to develop further a technology invented at LSU Health New Orleans with the aim to discover potential therapeutics to treat rare... Continue Reading

November 16, 2021

WKYC TV Interview: Science Helps to Develop New Weapons in Fight Against COVID-19

CLEVELAND — In 2020, during the height of the COVID-19 Pandemic, Harrington Discovery Institute at University Hospitals put out a call to scientists around the world: Send us your ideas to battle the coronavirus and we may fund your research.They received three hundred applications.All they needed was a fraction of the money... Continue Reading